Moderna (MEX:MRNA) Other Current Liabilities : MXN13,887 Mil (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Moderna Other Current Liabilities?

Moderna's other current liabilities for the quarter that ended in Jun. 2024 was MXN13,887 Mil.

Moderna's quarterly other current liabilities declined from Dec. 2023 (MXN14,292 Mil) to Mar. 2024 (MXN13,841 Mil) but then increased from Mar. 2024 (MXN13,841 Mil) to Jun. 2024 (MXN13,887 Mil).

Moderna's annual other current liabilities increased from Dec. 2021 (MXN2,872 Mil) to Dec. 2022 (MXN4,738 Mil) and increased from Dec. 2022 (MXN4,738 Mil) to Dec. 2023 (MXN14,292 Mil).

Moderna Other Current Liabilities Historical Data

The historical data trend for Moderna's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Other Current Liabilities Chart

Moderna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

Moderna Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Moderna Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Moderna Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Moderna's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Moderna Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (MEX:MRNA) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

MRNA:USA MRNA:Peru 1MRNA:Italy 0QFd:UK 0A45:UK 0QF:Germany M1RN34:Brazil 0QF:Bulgaria MRNA:Austria

Address

200 Technology Square, Cambridge, MA, USA, 02139

Website

https://www.modernatx.com

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.